| Literature DB >> 25775156 |
Qing-Wei Tan1,2, Fang-Luan Gao3,4, Fu-Rong Wang5, Qi-Jian Chen6,7.
Abstract
Plant-associated microorganisms are known to produce a variety of metabolites with novel structures and interesting biological activities. An endophytic fungus FJBJ11, isolated from the plant tissue of Brucea javanica (L.) Merr. (Simaroubaceae), was proven to be significantly effective in producing metabolites with anti-Tobacco mosaic virus (TMV) activities. The isolate was identified as Aspergillus tubingensis FJBJ11 based on morphological characteristics and ITS sequence. Bioassay-guided isolation led to the identification of a cycli penta-peptide, malformin A1, along with two cyclic dipeptides, cyclo (Gly-L-Pro) and cyclo (Ala-Leu). Malformin A1 showed potent inhibitory effect against the infection and replication of TMV with IC50 values of 19.7 and 45.4 μg·mL⁻¹, as tested using local lesion assay and leaf-disc method, respectively. The results indicated the potential use of malformin A1 as a leading compound or a promising candidate of new viricide.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25775156 PMCID: PMC4394503 DOI: 10.3390/ijms16035750
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Morphological characteristics of isolate FJBJ11. (a) Colonies growing in Czapek’s agar for 7 days; (b) The yellowish colonies observed from the reverse side of the Czapek’s agar; (c) Sporophore and spherical sporangium; (d) Conidia and sporangium with bilayer structure.
Figure 2Phylogenetic relationship of isolate FJBJ11 (accession No. KP196359) to representative sequences of known A. tubingensis and A. niger. Reference sequences were retrieved from GenBank and a T. verruculosus strain (accession No. KF998991) was served as an outgroup. The numbers on the branches are posterior probability (only shown >50) supporting the branch pattern. The isolate FJBJ11 from current study is marked with black dot. The distance unit is substitutions/site.
Figure 3Chemical structures of the cyclic peptides 1–3.
Figure 4Dose-dependent inhibition of malformin A1 against the replication of TMV as tested by using local lesion assay and leaf-disc method. Error bar: ±SD.
NMR data of malformin A1 (1).
| Amino Acid | Position | δH (mult., | δC (mult.) |
|---|---|---|---|
| Leu1 | C=O | – | 172.8 (s) |
| NH | 7.38 (d, 9.2) | – | |
| α | 4.47 (dt, 9.2, 2.8) | 50.4 (d) | |
| β | 1.37 (m) | 40.9 (d) | |
| γ | 1.56 (m) | 24.5 (d) | |
| δ | 0.89 (d, 6.6) | 22.7 (q) | |
| 0.85 (d, 6.6) | 21.8 (q) | ||
| Ile2 | C=O | – | 173.0 (s) |
| NH | 8.59 (d, 6.6) | – | |
| α | 3.87 (dd, 10.2, 6.6) | 58.0 (d) | |
| β | 1.69 (m) | 34.0 (d) | |
| γ | 1.50 (m); 1.13 (m) | 24.8 (t) | |
| 0.77 (d, 6.9) | 14.9 (q) | ||
| δ | 0.81 (t, 10.9) | 10.0 (q) | |
| Cys3 | C=O | – | 174.0 (s) |
| NH | 8.84 (d, 3.7) | – | |
| α | 3.98 (dd, 6.3, 3.3) | 52.4 (d) | |
| β | 3.51 (dd, 11.9, 3.2); 3.14 (m) | 46.2 (d) | |
| Cys4 | C=O | – | 169.8 (s) |
| NH | 7.11 (d, 11.0) | – | |
| α | 4.71 (dt, 11.0, 4.4) | 52.9 (d) | |
| β | 3.24 (m); 3.19 (m) | 45.2 (t) | |
| Val5 | C=O | – | 170.6 (s) |
| NH | 7.94 (d, 8.5) | – | |
| α | 3.92 (m) | 58.8 (d) | |
| β | 2.05 (m) | 26.9 (d) | |
| γ | 0.82 (d, 6.8) | 19.7 (q) | |
| 0.82 (d, 6.8) | 18.7 (q) |